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Introduction
Gut health is currently getting much attention among researchers and public. This mainly because many of the physical health
problems were found to closely connected to the improper functionality of gut. Over the years, study of the microbiological
system in the gut has slowly uncovered the general effects brought to the host. The concept of probiotic appears when effort is
made to modify or alter the composition of the microfloras in the gut to a remedial one by directly introducing the biologically
important beneficial microorganism. Currently, the prebiotic strategy is proposed as an alternative mode to improve the well
being of gut. This is the application of indigestible food ingredient that has impact on the metabolism of intestinal
microorganisms. In the scientific literature, most of the data on prebiotic effect deals with inulin and fructooligosaccharides,
and a range of commercial products have been available for many years. Due to the potential synergy between probiotic and
prebiotic, foods containing a combination of these ingredients are often referred to as synbiotic. One may also expect the
prebiotic to serve as a preliminary growth substance while introducing a special functionality of probiotic into the gut. This is
especially important in view of the weakness of probiotic surviving through gastrointestinal tract to reach an allocated site such
as small and large bowel. On the other hand, the correct pair of probiotic and prebiotic is designed to insure a successful
establishment of probiotic in the gut among the present of the large microbial assemblage. This is true when the substrate
affinity of the probiotic, for example Bifidobacterium, is varied according to species and even up to the strain level.
Materials and Methods
Peptone Yeast Glucose (PY-G) broth previously formulated by Holdeman and Moore (1977) for the cultivation of intestinal
bacterial was modified for the screening of inulinase activity from the array of wild type Bifidobacterium pseudocatenulatum.
The only changes were the carbon source (glucose) used to oligofructose as pY-O and inulin as PY-I with the addition of agar.
Positive results were indicated by the yellow zone appeared on the agar due to bromecresol purple as the acid indication. The
best strain was selected from this screening test and its maximum specific growth rate (umax) was determined for the purpose
of obtaining the suitable dilution rate in the continuous cultivation. The same umax was found in the case of the challenge
harmful microorganism employed (in this case: E. coli VIS7). In therapeutic study. two different concentrations of
bifidobacteria were used to challenge the growth of E. coli VIS7 in the continuous system (lOS cfuJmL and 108 cfulmL). The
higher concentration was prepared via consecutive propagation of bacterial cell in a batch system. The bacteria cells were
harvested by refrigerated centrifugation (8000 rpm for 20 min at 2°C). Pellet cell obtained was suspended in S ml peptone
water (50 % glycerol. v/v) and was further kept in a 12 mL sterile syringe under refrigerated condition (_200q before seeding
for maximum 3 days. The continuous cultivation was initiated when the maximum number of E. coli Vl57 achieved, normally
after 6 h of incubation. Bifidobacteria was inoculated into the system for at least after 3 resident times of E. coli VIS7
cultivation. The antagonistic activity of B. pseudocatenulatum F 117 against E. coli V157 was further evaluated by growth
profile, acidification activity, and organic acid production during interaction. For prophylactic study. the experimental
conditions were the same except that B. pseudocatenulatum F 117 was to be initially cultivated before seeding in E. coli V157.
For both experiment, glucose (0.5 %) and oligofructose (0.5 % and 1.0 %) were the main parameter monitored to evaluate for
synergistic effect of bifid abaete ria and prebiotic on antagonism.
Results and Discussion
All B. pseudocatenulatum screened showed excellent growth on pY-O agar with high acid production. The yellow zone
appeared to be large (2:2Smm) and obvious. This observation was true to all wild type strains, B. pseudocatenulatum and also
the commercial reference strain, B. pseudocatenulatum JCM 1200. B. in/antis ATCe 15698 exhibited moderate growth on
PY -0 agar with small (15m~x<25mm) but clear yellow zone. B. breve ATCC 29720 and B. longum 8B536 produced barely
obvious zone (Smrrrsx-cl Smm) on this agar which indicated poor growth. Meanwhile, all B. pseudocatenulatum demonstrated
poor growth on PY-l agar but for strain FI17 and JCM 1200, which displayed moderate growth. No yellow zone «5mm)
observed on PY-I agar for the rest of the three reference strains: B. in/antis. B_ breve and B. longum. This implicit in the absent
of acidification activity by these strains. Therefore, B. pseudocatenulatum was suspected to possess high activity in utilizing
oligofructose and mulin. In that respect, enzyme inulinase must be highly induced for the purpose of breaking down the
specific J3-(2-1) linkages in these molecules.
In batch culture, for B. pseudocatenulatum Fl J 7, JIm'was calculated as 0.22 h'!, 0.25 h'! and 0.19 h'! in glucose, oligofructose
and inulin respectively. However, for E. coli V 157, JImwas determined as 1.00 h", 1.10 h-! and 1.20 h'! in the corresponding
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medium. 11m in range ofO.to h" to 0.12 h·1 was employed in the continuous interaction of B. pseudocatenulatum FI17 and E.
coli V157.
In therapeutic study. pH constant at 6.80 was suspected to affect the growth of freshly seeded B. pseudocatenulatum FI17,
which unable to proliferate to a higher count. On the contrary, growth stimulation was observed when B. pseudocatenulatum
F 117 were introduced into this similar condition except further monitoring of pH. pH lowering was presumably due to increase
in organic acids concentration when the population of B. pseudocatenulatum F 117 have considerably elevated. Lactic acid, a
central organic acid in associate with bifidobacteria for the typical bifid shunt though, was not measured. However, batch
cultivation with the same growing conditions obser ved an intense amount of lactic acid produced particularly in the initial
stage of growth. In summary, under-detection of this compound might be ascribed to poor growth which rendered in the lost of
competition for substrates available compared to E. coli \" 157. In addition to that, lactic acid was detected to profusely induce
in respond to cell growth for batch cultivation of B. pseudocatenulatum F 117. Consequently, lactic acid might be of
chemically important in terms of growth.
By substituting oligofructose as the principal substrate to glucose, two interesting observations were operated concurrently. A
more rapid acidification activity in line with profound growth of B. pseudocatenulatum F 117 was noted. An enhanced growth
rate once B. pseudocatenulatum F I 17 was seeded into the continuous flow system was definitely a critical characteristic. It has
further approved that oligofructose formerly as the best growth substrate to B. pseudocatenulatum F 117 in batch cultivation
performed equally well to accelerate growth in continuous cultivation. Again, this could be a considerable criterion of prebiotic
to immediately serve as colonic food for particular probiotic and to the greater extends stimulate its growth.
The study with a lower B. pseudocatenulatum F117 dose (I O~cfu/rnl.) in control exhibited a relatively analogous antagonism
on E. coli V 157 compared to a higher dose (10' cfu/ml.) used. Besides, the antagonism prevailed could be separated into two
interesting phases. First, while B. pseudocatenulatum F 117 was growing to the maximum count and next was after this
maximum count achieved. It was found that appropriate B. pseudocatenulatum FI17 numbers was rather important, as the
antagonistic activity was constantly proved to be higher in the second phase of interaction for either bacterial dose employed.
Nevertheless, both B. pseudocatenulatum FI17 doses consumed equally same duration to achieve the maximum growth, thus
seemingly implied that lower B. pseudocatenulatum FI17 dose performed comparably excellent to a higher dose. In condition
with oligofructose fortified medium, no observation with regard to shortening of span for B. pseudocatenulatum F 117 to
achieve the maximum growth. Nevertheless, a growth stimulation response was still being detected immediately after seeding
of B. pseudocatenulatum F 117 into this environment (the first 6h) compared to control with slower growth rate. Lactate
production again was stimulated in this medium, as this compound has yet appeared in control at the same time even though a
comparable count of B. pseudocatenulatum FI17 was assessed in both conditions. Stimulation in lactate production was
therefore seemed to have a significant utility both for the growth of B. pseudocatenulatum F 117 and also the antagonistic
effect.
Current study with higher oligofructose dose did not observe to improve the maximum growth of B. pseudocatenulatum FI17
from a lower oligofructose dose assessed. Meanwhile, B. pseudocatenulatum F 117 could hardly raise up to log 9 cfulmL in
count as was normally achieved in all other cases. However, the antagonistic effect received by E. coli VI57 was somehow
greatly induced. When the pH declination trend was determined with respect to the lower oligofructose dose used, no apparent
justification could be done. In all, a higher organic acids concentration was much significant to address for such an effect.
In prophylactic study, experimental results demonstrated that oligofructose did not significantly increase the resistance of B.
pseudocatenulatum FI17 against colonization of incoming E. coli Vl57 when glucose was available as growth substrate.
However, E. coli VI57 was unable to sustain in these systems with B. pseudocatenulatum FI17 observed to have higher
stability in its viable counts. In PY-G medium, E. coli VI57 has demonstrated sign of resistance after an earlier 12 h of growth
reduction. This resistance lasted for 12 h before a more susceptible effect ensued. During this duration, acetic acid was found
to have drastically decreased in concentration. This might infer that E. coli V157 was capable of metabolizing acetic acid as
growth substrate. However, a further decrease in pH disabled this metabolism to continue. On the other hand, the rate by which
E. coli V 157 eliminated from the system was not enhanced because of prebiotic (PY-0 medium), but a slow and constant rate
prevailed. During this period (30 h), acetic acid was also decreasing in concentration, again deducing the metabolism of this
compound by E. coli VIS7, especially when oligofructose was not a good energy source as discussed earlier on. Lowering of
pH discouraged the growth of E. coli V157, and conversely this condition supported the growth of B. pseudocatenulatum
F 117. Nonetheless, the growth of B. pseudocatenulatum F 117 was only limited to log 9 cfulmL in this system.
Conclusions
Screening experiment on inulinase activity for oligofructose and inulin has obviously shown that although generally regarded
as authentic prebiotic for Bifidobacterium spp., however. the fact could be only reliable to certain strains but not the overall
species. Wild type B. pseudocatenulatum F 117 was found the best inulin and oligofructose utilizer and was therefore selected
for advance study. Batch cultivation revealed that B. pseudocatenulatum FI17 was well grown in oligofructose fortified
medium instead of glucose or inulm fortified medium. A much higher organic acids production mainly of lactic, acetic and
formic acid further approved the unique characteristic of oligofructose and was thus chosen specifically as prebiotic in
therapeutic and prophylactic study In therapeutic study, basically, pH and organic acids such as acetic, lactic and formic acid
were the essential inhibitory agent towards the growth of E. coli V157. Most relatively differ and higher was the production of
lactic acid from the fermentation of oligofructose to that of glucose. This compound was found to be more important as an
acidification agent and also the cytotoxic factor rather than the commonly known acetic acid. Also, at low pH condition, a
higher organic acids concentration could render in a greater inhibitory effect. Nevertheless, these organic compounds were
observed to profusely produce when the numbers of bifidobacteria was at its maximum. Therefore, the numbers of
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bifidobactcria (cfu/ml.) available for effective interaction was become rather important. In the study of bifidobacteria dose
(cfu/rnl.) effect on the growth commencement, the observation was that low initial loads, 105 cfulmL performed comparably
effective to the higher dose, 10' cfulmL. In both options, the significant antagonism was assessed when the maximum growth
of bifidobacteria attained (IOQ cfu/rnl.), And, it happened that both bifidobacteria doses exhibited almost the same duration for
the maximum growth achieved. Nonetheless. when oligofructose was used as the carbon source (rather than glucose), the
antagonism displayed much earlier, even before the expected maximum growth due. In the prophylactic study, nevertheless,
there wasn't obvious improvement of B. pseudocatenulatum F 117 by oligofructose to resist the exogenously introduced E. coli
V 157 as compared to glucose as carbon or energy supply. The pH and organic acids production to this context were
insufficient to address for such an occurrence. However, in therapeutic and prophylactic study, the antagonism was much
enhanced when the oligofructose concentration used in PY -0 medium increased (from 0.5 % to 1.0 %). A more dramatic
antagonistic interaction was illustrated by the elevation of organic acids concentration along with rapid acidification.
Nonetheless. too acidic condition was found detrimental to the growth of D. pseudocatenulatum F117.
Benefits from the study
The combination of probiotic (D. pseudocatenulatum F117 and prebiotic (oligofructose) that can fulfilled the criterion of
synbiotic (synergistic pair) was found. The effect of oligofructose to stimulate the growth of bifidobacteria was further
explained in terms of organic acid production. Suitable dose of bifidobacteria for effective therapeutic function could be
employed. Oligo fructose as prebiotic can work to improve the establishment of bifidobacteria community in the allocated
niches of gut. All these studies effectively provide a guideline for future clinical study.
Patent(s), if applicable
D. pseudocatenulatum F II 7 and oligofructose as "synbiotic pair"
Stage of Commercialization, if applicable:
Nil
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